The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
EBMT 2016 | Next steps for novel treatments in multiple myeloma
Bruno Paiva, PhD, from the University of Navarra, Pamplona, Spain discusses the current status of novel treatments in multiple myeloma (MM). According to Dr Paiva, the last three years have seen important advances for transplant eligible and ineligible MM patients. There are two questions that need to be addressed: how to combine the new agents with the current backbone therapy and how to combine the various individual novel drugs.
Recorded at the 2016 Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) in Valencia, Spain.
